Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Sigrid Therapeutics AB

Closing information (x1000 NOK)

Closing information 2023/12 2022/12 2021/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 0 Equal arrow 0 Equal arrow 0
Earnings before taxes -31,006 More Arrow -20,698 More Arrow -20,225
EBITDA -31,335 More Arrow -20,356 More Arrow -19,813
Total assets 74,389 Less Arrow 52,037 More Arrow 63,269
Current assets 67,640 Less Arrow 48,969 More Arrow 60,824
Current liabilities 9,810 Less Arrow 4,340 Less Arrow 3,559
Equity capital 64,579 Less Arrow 47,697 More Arrow 59,710
- share capital 735 Less Arrow 620 More Arrow 627
Employees (average) 7 More Arrow 9 Less Arrow 7

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 86.8% More Arrow 91.7% More Arrow 94.4%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -41.7% More Arrow -39.8% More Arrow -32.0%
Current ratio 689.5% More Arrow 1128.3% More Arrow 1709.0%
Return on equity (ROE) -48.0% More Arrow -43.4% More Arrow -33.9%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees -2 More Arrow 2 Equal arrow 2
Chg. No. of employees % -22% More Arrow 29% More Arrow 40%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.